Return to home page
Searching: Otterbein library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
EBOOK
Author Paavilainen, Helena M.
Title Medieval pharmacotherapy, continuity and change : case studies from Ibn Sīnā and some of his late Medieval commentators / by Helena M. Paavilainen.
Imprint Leiden ; Boston : Brill, 2009.

Author Paavilainen, Helena M.
Series Studies in ancient medicine, 0925-1421 ; v. 38
Studies in ancient medicine ; v. 38.
Subject Avicenna, 980-1037.
Pharmacology -- History.
Medicine, Medieval.
Pharmacopoeias.
Drug Therapy -- history.
History, Medieval.
Medicine, Arabic -- history.
Drug Therapy -- history.
History, Medieval.
Medicine, Arabic -- history.
Description 1 online resource (xix, 795 pages).
polychrome rdacc
Bibliography Note Includes bibliographical references and index.
Contents Historical background -- Research material -- Method of the study -- Nosebleed -- Cough -- Diabetes.
Summary The development of medical drug therapy in medieval times is an interplay between tradition and innovation. This book tracks the changes in drug recommendations from the Arabic texts of Ibn SAnA to Latin medical scholasticism, demonstrating their essential rationality.
Note Print version record.
ISBN 9789047424505 (electronic bk.)
9047424506 (electronic bk.)
1282602527
9781282602526
9789004171190 (hardback ; alk. paper)
9004171193 (hardback ; alk. paper)
ISBN/ISSN 10.1163/ej.9789004171190.i-796
OCLC # 593336792
Additional Format Print version: Paavilainen, Helena M. Medieval pharmacotherapy, continuity and change. Leiden ; Boston : Brill, 2009 9789004171190 (DLC) 2009029999 (OCoLC)428770797


If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team